Name: AUPH Income Statement - Aurinia Pharmaceuticals Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

AUPH - Aurinia Pharmaceuticals Inc.

USD | NASDAQ | Healthcare

AUPH Income Statement - Aurinia Pharmaceuticals Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20
Revenues
Revenues	77.7	77.1	73.5	70.0	62.5	59.9	67.8	57.2	50.3	45.1	54.5	41.5	34.4	28.4	55.8	28.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Revenues
Revenues	298.3	283.1	235.1	175.5	134.0	45.6	50.1	0.3	0.5
Cost of Revenue	30.6	32.7	28.2	14.1	5.7	1.1	0.0	0.0	-
Gross Profit	267.7	250.4	206.9	161.4	128.4	44.5	50.1	0.3	-
Operating Expenses
Research & Development	34.2	32.5	20.8	49.6	45.0	51.1	50.3	52.9	41.4
Selling General & Administrative	-	-	-	195.0
Operating Income
Operating Income	124.5	104.9	(4.7)	(91.7)	(111.5)	(180.7)	(104.3)	(90.9)	(55.2)
Non-Operating
Interest Income	13.5	13.6	17.0	17.0	5.1	0.5	1.5	2.7	2.2
Interest Expense	4.3	4.3	4.8	2.8	0.0
Tax & Net
Income Tax Expense	(164.5)	(173.0)	1.7	0.6	1.8	0.8	(0.1)	0.1	0.1
Net Income From Continuing Ops	298.2	287.2	5.8	(78.0)
Per Share
EPS Basic	2.25	2.14	0.04	(0.54)	(0.76)	(1.40)	(0.87)	(0.95)	-
EPS Diluted	2.17	2.07	0.04	(0.54)	(0.76)
Supplementary Data
EBITDA	-	124.4	14.8	(80.0)	(108.8)	(178.0)	(102.9)	(90.9)	(55.2)
EBIT	124.5	104.9	(4.7)	(91.7)	(111.5)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	7.5	10.9	8.4	7.4	5.7	8.1	3.0	4.1	5.6	10.2	13.6	12.7	13.2	9.9	11.0	11.5	12.6	11.1	20.1	10.1	9.8	13.2	12.2	11.1	13.8
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	22.0	29.3	26.2	26.0	20.3	37.0	42.4	44.9	47.7	50.1	47.8	47.1	50.1	47.5	52.2	51.5	45.2
Depreciation & Amortization	4.8	-	-	-	4.9	-	-	-	4.8	-	-	-	0.7	-	-	-
Amortization of Intangibles	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.5	0.5	0.6	0.5	0.5	0.5
Other Operating Expenses	(0.3)	5.1	(0.9)	(9.2)	(4.4)	4.5	(4.6)	0.3	4.1	(9.1)	(2.6)	3.6	(0.3)	2.2	0.3	0.5	(1.4)
Total Operating Expenses	36.3	43.9	43.7	49.9	40.6	61.5	56.0	58.7	63.6	74.8	70.8	57.7	64.0	56.5	65.3	64.2

Operating Income
Operating Income	41.4	33.2	29.7	20.1	21.8	(1.7)	11.7	(1.5)	(13.3)	(29.7)	(16.3)	(16.2)	(29.6)	(28.1)	(9.5)	(36.0)	(37.9)	(32.7)	(50.4)	(47.1)	(50.5)	(8.1)	(42.3)	(26.9)	(27.1)

Non-Operating
Interest Income	3.5	3.5	3.3	3.2	3.6	4.0	4.3	4.2	4.5	-	4.5	-	-	-	-	-	-	-	-	0.1	0.2	-	-	0.3	0.9
Interest Expense	1.0	1.0	1.1	1.1	1.1	1.1	1.2	1.2	1.3	1.3	1.4	0.1	0.0	-	0.0	0.0	-	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	43.9	35.7	32.0	22.2	24.3	1.2	14.8	1.5	(10.0)	(26.4)	(13.1)	(12.1)	(25.8)	(25.2)	(8.0)	(35.5)

Tax & Net
Income Tax Expense	9.6	(175.1)	0.4	0.6	1.0	(0.3)	0.5	0.8	0.7	0.5	0.3	(0.6)	0.4	0.9	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	(0.0)	0.0	(0.2)
Net Income From Continuing Ops	34.4	210.8	31.6	21.5	23.3	1.4	14.4	0.7	(10.7)	(26.9)	(13.4)	(11.5)	(26.2)	(26.0)	(9.0)	(35.5)	(37.6)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	34.4	210.8	31.6	21.5	23.3	1.4	14.4	0.7	(10.7)	(26.9)	(13.4)	(11.5)	(26.2)	(26.0)	(9.0)	(35.5)	(37.6)
Net Income Attributable To Parent	34.4	210.8	31.6	21.5	23.3	1.4	14.4	0.7	(10.7)	(26.9)	(13.4)	(11.5)	(26.2)	(26.0)	(9.0)	(35.5)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	34.4	210.8	31.6	21.5	23.3	1.4	14.4	0.7	(10.7)	(26.9)	(13.4)	(11.5)	(26.2)	(26.0)	(9.0)

Per Share
EPS Basic	0.26	-	0.24	0.16	0.17	-	0.10	0.01	(0.07)	-	(0.09)	(0.08)	(0.18)	-	(0.06)	(0.25)	(0.27)	-	(0.39)	(0.37)	(0.40)	-	(0.34)	(0.24)	-
EPS Diluted	0.25	-	0.23	0.16	0.16	-	0.10	0.01	(0.07)	-	(0.09)	(0.08)	(0.18)	-	(0.06)	(0.25)	(0.27)	-
Shares Basic	132.4	-	131.8	134.9	138.9	-	143.1	143.3	144.0	-	142.8	142.8	142.6	-	141.9	141.7	141.7	-
Shares Diluted	137.6	-	136.0	137.5	143.2	-	145.7	144.1	144.0	-	142.8	142.8	142.6	-	141.9	141.7	141.7	-

Supplementary Data
EBITDA	46.2	-	-	-	26.7	-	-	-	(8.4)	-	-	-	(28.9)	-	-	-	(37.2)	(31.0)	(50.2)	(46.9)	(49.9)	(6.7)	(42.3)	(26.9)	(27.0)
EBIT	41.4	33.2	29.7	20.1	21.8	(1.7)	11.7	(1.5)	(13.3)	(29.7)	(16.3)	(16.2)	(29.6)	(28.1)	(9.5)	(36.0)	(37.9)	(32.7)	(50.4)